Home/Filings/3/0000899243-21-007416
3//SEC Filing

EW Healthcare Partners Fund 2-UGP, L.P. 3

Accession 0000899243-21-007416

CIK 0001561921other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:25 PM ET

Size

12.8 KB

Accession

0000899243-21-007416

Insider Transaction Report

Form 3
Period: 2020-12-31
Holdings
  • Common Stock, $0.001 per share

    599,853
  • Common Stock, $0.001 per share

    875,440
  • Common Stock, $0.001 per share

    (indirect: See footnotes)
    1,475,293
  • Common Stock, $0.001 per share

    (indirect: See footnotes)
    1,475,293
Footnotes (2)
  • [F1]EW Healthcare Partners Fund 2, L.P., is the holder of 599,853 shares and EW Healthcare Partners Fund 2-A, L.P., is the holder of 875,440 shares of the Issuer. EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers.
  • [F2]Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001793948

Filing Metadata

Form type
3
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:25 PM ET
Size
12.8 KB